Ms Contin (Morphine Sulfate)

Morphine sulfate, the active ingredient in Ms Contin, is an opioid analgesic presented as an oral tablet for oral use. It is employed to manage moderate to severe pain in adult patients when alternative analgesics are insufficient or unsuitable.

GNH USA supplies Ms Contin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for import and distribution. Our global network ensures reliable delivery to diverse healthcare settings.

Ms Contin (morphine sulfate) is an opioid analgesic used in the management of pain across several clinical contexts.

Acute postoperative pain: provides rapid analgesia to facilitate recovery after surgery. Cancer‑related pain: offers sustained relief for moderate to severe nociceptive pain associated with malignancy. Chronic non‑cancer pain: reduces persistent pain when other treatments are inadequate.

Ms Contin may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Constipation: reduced gastrointestinal motility leading to hard stools. - Nausea: feeling of queasiness often accompanied by vomiting. - Drowsiness: increased sleepiness or reduced alertness. - Dizziness: sensation of light‑headedness or imbalance.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing that can be life‑threatening. - Severe hypotension: marked drop in blood pressure causing faintness or shock. - Dependence or addiction: development of physical or psychological reliance on the drug. - Adrenal insufficiency: impaired cortisol production leading to fatigue and electrolyte disturbances.

When prescribing Ms Contin, clinicians should consider several safety measures.

Assess pain severity and prior opioid use: determine appropriate need for opioid therapy. Screen for respiratory disorders: avoid use in patients with severe asthma or COPD. Monitor for signs of sedation or respiratory depression: especially during dose titration. Avoid concurrent use with other central nervous system depressants: increased risk of respiratory depression. Pregnancy and lactation: use only if benefits outweigh risks; consult obstetric specialist. Store at ambient temperature: keep in original container, protect from moisture and light.

Ms Contin can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Concomitant use with other opioids: additive respiratory depression. - Benzodiazepines or barbiturates: heightened CNS depression. - MAO inhibitors: risk of severe hypotension and serotonin syndrome. - CYP3A4 inhibitors (e.g., ketoconazole): increased morphine plasma levels. - Respiratory depressants (e.g., anesthetic gases): profound respiratory suppression.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampin): reduced efficacy. - Anticholinergic agents: may worsen constipation. - Diuretics: potential for hypotension. - Antidepressants (SSRIs): possible serotonin syndrome risk. - Alcohol: enhances sedative effects.